Project Grant K08AI190125
Award Date
7/1/25
Completion Date
6/30/30
Dollars Obligated
$199K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This federal Project Grant award, totaling $711,555.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The overarching goal of this 5-year project, awarded on May 13, 2025 and running through April 30, 2030, is to contribute to the fundamental understanding of the spatiotemporal transmission dynamics and control of vaccine-preventable childhood infections. The project aims to develop...
This Project Grant award of $699,339, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 "Allergy and Infectious Diseases Research", will support a 5-year research project to study the transmission dynamics of dengue and Zika viruses in northwestern coastal Ecuador. The research team, led by the University of Michigan, will conduct parallel longitudinal studies of human and mosquito populations across diverse communities to characterize how...
This $146,922 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research program) to Emory University supports research to better understand factors that influence the efficiency of influenza A virus (IAV) infection. The project will use barcoded IAV libraries and guinea pig models to investigate how the mode of virus exposure (direct contact vs. airborne) and environmental conditions like temperature and...
The federal Project Grant award of $700,288 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to identify genetic factors associated with the development of sexual stages (gametocytes) in the malaria parasite Plasmodium falciparum. The project combines expertise in gametocyte biology, advanced computational genomics, and phenotype comparisons with clinical...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a longitudinal cohort study to examine the impact of early childhood malaria prevention interventions on malaria risk in school-age children in Ghana. The study, titled "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)", will evaluate the epidemiological and...
This federal Project Grant award, with a total funding amount of $1,553,810, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant aims to develop a genomic surveillance approach to identify mutations under selection in functional pathways associated with artemisinin resistance in Plasmodium falciparum malaria parasites in Africa. The key objectives are to: 1) identify parasite loci...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $355,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Georgia Southern University Research & Service Foundation Inc. The grant will support research to develop comprehensive morphological and molecular identification tools for Hyalomma tick species that are vectors of Crimean-Congo Hemorrhagic Fever virus. The project aims to resolve the systematics of closely related...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $681,278 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The grant, which runs from July 2024 to May 2026, will fund research to characterize the HIV latent reservoir and model the contributions of antigen-driven and homeostatic proliferation to its persistence in people living with HIV on antiretroviral therapy. The goal is to help design future HIV...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to discover the targets of naturally acquired protection against severe Plasmodium falciparum malaria and develop them as novel blood-stage vaccine candidates. The award, totaling $708,202 and effective from December 2024 through November 2029, will support research at Brown University to identify the parasite...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $2,065,600.00 to investigate the paradox of non-reciprocal flavivirus immunity. The grant, awarded on July 24, 2024 with an ultimate completion date of May 31, 2029, will integrate studies in nonhuman primate models and human cohorts to evaluate the impact of flavivirus exposure on antibody repertoire...